Type 2 Diabetes Trial, Recruiting NCT04326192 Sponsor: Oregon Health and Science University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT04326192
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 21 and 70 years old
  • People who have ongoing nerve-related pain in their legs and back
  • People who are already planning to have a spinal cord stimulator (a device implanted to help manage pain) fitted
  • People who have never previously had a spinal cord stimulator trial for pain
  • People whose Body Mass Index (BMI — a measure based on height and weight) falls between 25 and 45

Who may not be able to join:

  • People who are not planning to have a spinal cord stimulator for pain
  • People who are under the supervision of the legal or justice system (forensic patients)
  • People who are currently taking beta blocker medications (a type of heart or blood pressure medicine)
  • People whose weight has changed by more than 5% in the last 3 months
  • People who regularly use tobacco products
  • People who regularly drink excessive amounts of alcohol
  • People who are pregnant
  • People who are not able to make their own informed decisions about participating
  • Children and teenagers (under 21 years of age)
  • Newborn babies
  • People with a BMI below 25 or above 45

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kim Burchiel, MD, Oregon Health and Science University

Phone: 503-494-4314

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 February 2021
Est. completion
1 October 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

SUVmax

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov